Recent events
Recent events tied to this brand in public sources.
Back to profile31 entries · Page 2 of 2
2020
Medtronic completes acquisition of Medicrea
Medtronic announced that it had completed its tender offer for Medicrea and owned more than 90% of Medicrea's share capital and voting rights. Medtronic said it would shortly request a squeeze-out procedure under French law.
2020
Apollo and Medtronic stroke-management AI partnership
Apollo partnered with Medtronic to integrate AI for stroke management. Apollo said the system would standardize diagnosis and help clinicians make faster, more accurate diagnosis and treatment decisions.
2020
Medtronic launches Azure pacemaker in India
Medtronic announced the launch in India of the Azure pacemaker with BlueSync technology, which can communicate directly with patients' smartphones and tablets.
2020
FDA approves Medtronic Percept PC DBS system
Medtronic announced that it received FDA approval for the Percept PC Deep Brain Stimulation system with BrainSense technology.
2020
FDA recalls certain MiniMed 600 series insulin pumps
The FDA issued a Class I recall covering more than 322,000 Medtronic MiniMed 600 series insulin pumps because a defective retainer ring may cause insulin over- or under-delivery. The article reports more than 26,000 complaints, 2,175 injuries and one death related to the pumps.
2019
ChristianaCare and Medtronic sign five-year partnership
ChristianaCare and Medtronic signed a five-year agreement to share the financial risk and savings associated with patient outcomes, using digital technology to support care decisions.
2019
ViewRay and Medtronic announced a clinical collaboration memorandum
ViewRay announced that it signed a non-binding memorandum of understanding with Medtronic to enter into a clinical collaboration, including exploring clinical benefits of the MRIdian MR-guided radiation therapy system. Medtronic committed to invest in a minority interest in ViewRay, subject to a commitment agreement.
2019
Medtronic reports fiscal 2020 second-quarter results
Medtronic reported second-quarter fiscal 2020 revenue of $7.706 billion and diluted GAAP EPS of $1.01 for the quarter ended October 25, 2019.
2019
Medtronic raises fiscal 2020 EPS guidance
Medtronic raised its fiscal 2020 diluted non-GAAP EPS guidance from $5.54–$5.60 to $5.57–$5.63.
2019
Medtronic launches DBS patient programming system using a Samsung smartphone
Medtronic launched a system allowing patients to manage deep brain stimulation treatments at home using a dedicated, customized Samsung smartphone. The U.S. commercial launch was announced at the Samsung Developers Conference.
2017
Medtronic and The Foundry partner to develop mitral valve repair technology
Medtronic announced a partnership with The Foundry to invest in and create a company to develop transcatheter mitral repair technology. The arrangement includes structured investments from both parties and gives Medtronic an exclusive right to acquire the resulting company, Half Moon Medical, if certain technical and clinical milestones are achieved.